Category Archives: Pr Newswire

MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HONG KONG, July 11, 2024 /PRNewswire/ — MMTEC, Inc. (NASDAQ: MTC) (“MMTEC”, “we”, “our” or the “Company”), a China-based technology company that provides access to the U.S. financial markets, today announced that on July 8, 2024, the Company received a notification letter (the “Notification Letter”) from the Listings Qualifications Department of The Nasdaq Stock Market LLC […]

IMBOX Protection, World’s Only In-Store Footwear Protection Technology, Expands in Asia, Partnering with Hong Kong-based Sports Retailer Sportshouse

Beginning July 9, 2024, Consumers Will Find Imbox Protection in Stores Providing a PFAs-Free Treatment in 60 seconds at Check Out DENMARK and HONG KONG, July 11, 2024 /PRNewswire/ — IMBOX Protection, the world’s only in-store footwear protection technology, is expanding its presence in Asia beginning July 9, 2024, partnering with Hong-Kong-based Sportshouse, a leading sports […]

IFS Acquires EmpowerMX

EmpowerMX’s powerful MRO technology adds further differentiation and depth to IFS’s Industrial AI proposition for Aerospace & Defense FRISCO, Texas, July 11, 2024 /PRNewswire/ — IFS, the leading technology innovator in cloud and Industrial AI software, today announces the acquisition of EmpowerMX. EmpowerMX is an AI-powered aviation maintenance software provider specializing in Airframe Maintenance Repair and […]

EDIFIER STAX SPIRIT S5 Wireless Planar Magnetic Headphones

Wireless Planar Magnetic Headphones to accurately represent a superior audio experience. The 2nd gen EqualMass™ wiring technology and 2μm thin film lend the STAX SPIRIT S5 a performance comparable to legendary electrostatic headphones. Production Phase Auto Calibrate guarantees that every set of S5 headphones delivers a sound fidelity identical to the original model crafted by […]

Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii

RECCE® 327 (R327) demonstrated significant bactericidal activity against ‘superbug’ Acinetobacter baumannii (A. baumannii) demonstrating 99.99999% log reduction (>7.5 log reduction) in adult human epidermal ‘skin’ cells A. baumannii is most commonly responsible for urinary tract infections, ventilator-associated pneumonia, central line-associated bloodstream infections, persistent wound infections and meningitis The data supports upcoming Phase II Acute Bacterial […]

Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results

SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and conference call, senior leaders will provide an overview of […]

Tr1X Announces First Patient Dosed in Proof of Concept GvHD Trial Evaluating TRX103, a First-in-Class Type 1 Treg (Tr1) Cell Therapy

TRX103 is designed to reset the immune system, improve clinical outcomes, and potentially cure patients suffering from autoimmune and inflammatory disorders This marks the first use of an allogeneic engineered Type 1 Treg (Tr1) cell therapy in clinical trials. The first patient has successfully cleared the safety period with no serious adverse events. Additional preliminary […]

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024

SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on Wednesday, August 7, 2024, and will host a conference call and […]

Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July

CEO to participate in ARVO SIG panel on oral medications for retinal diseases ZETA-1 Phase 2 clinical trial subset analysis to be presented during the ASRS 42nd Annual Scientific Meeting FARMINGTON HILLS, Mich., July 10, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule […]

Recurrent Energy Signs PPA with GKN Automotive for 115 MWp Rey I Project in Spain

GUELPH, ON, July 10, 2024 /PRNewswire/ — Recurrent Energy, a subsidiary of Canadian Solar Inc. (“Canadian Solar”) (NASDAQ: CSIQ) and a global developer,  owner, and operator of solar and energy storage assets, announced today that it has signed a 10-year Power Purchase Agreement (PPA)  with GKN Automotive, the global leader in drive systems. This agreement […]